Fresh out of stealth, Switchpoint Bio raises €4.75 million to decode disease and drug response through blood tests
Switchpoint Bio, a Helsinki- and Cambridge-based TechBio startup, has secured €4.75 million in pre-Seed funding to develop its blood-based epigenomic platform aimed at revolutionizing drug…
EU-Startups FinlandRead the story →


